Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
admin Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read Moreendpoints
AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with…
Read MoreNovartis hemoglobinuria trial meets two primary endpoints
Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug to…
Read More